Organon & Co.
OGN
OGN: Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada.
moreShow OGN Financials
Recent trades of OGN by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Hickenlooper, John Senate / D | Sale (Full) $1,001 - $15,000 | Jun. 28, 2021 |
Recently reported changes by institutional investors
Quarterly net insider trading by OGN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on OGN's company Twitter account
Number of mentions of OGN in WallStreetBets Daily Discussion
Recent insights relating to OGN
Recent picks made for OGN stock on CNBC
ETFs with the largest estimated holdings in OGN
Flights by private jets registered to OGN